Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes

British Journal of Haematology

Volumn 107, Issue 4, 1999, Pages 844-850

  Rigolin, Gian Matteo ^a   Howard, Julie ^a   Buggins, Andrea ^a   Sneddon, Claire ^a   Castoldi, Gianluigi ^b   Hirst, William J R ^a   Mufti, Ghulam J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Dendritic cells; FISH; Immunophenotype; Mixed lymphocyte reaction; Myelodysplastic syndromes

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL COUNT; CELL CULTURE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; MONOCYTE; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033389158     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01781.x     Document Type: Article

References (24)

1. Banchereau, J. & Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature, 392, 245-252.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, G., Gralnick, H. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
3. + T cells in vitro. Blood, 91. 4652-4661.
4. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A. & Blay, J.Y. (1997) The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunology Today. 18, 493-497.
5. Choudhury, A., Gajewski, J.L., Liang J.C., Popat, U., Claxton, D.F., Kliche, K.O., Andreeff, M. & Champlin, E. (1997) Use of leukemic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood, 89, 1133-1142.
6. Choudhury, A., Thomas. J.C., Flore-Romo, L., Xie, Q.S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R.E. & Claxton, D.F. (1999) Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood, 93, 780-786.
7. Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., Ohyashiki, K., Toyama, K., Aul, C., Mufti, G. & Bennett, J. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, 2079-2088.
8. Hamblin, T.J. (1996) Immunological abnormalities in myelodysplastic syndromes. Seminars in Hematology, 33, 150-162.
9. Hart, D.N.J. (1997) Dendritic cells: unique leukocyte populations, which control the primary immune response. Blood, 90, 3245-3287.
10. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwiniski, D., Taidi, B., Engleman, E.G. & Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine, 2, 52-58.
11. Inaba, K., Pack, M., Sakuta, M., Isdell, F. & Steinmann, R.M. (1997) High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. Journal of Experimental Medicine, 186, 665-672.
12. Lanza, F., Castagnari, B., Rigolin, G., Latorraca, A., Ferrari, L., Bardi, A. & Castoldi, G. (1997) Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells. Leukemia, 11, 1700-1710.
13. + progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood, 92, 4778-4791.
14. Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Yuansheng, Grabbe, S., Dummer, R., Burg, G. & Schadendorf, D. (1998) Vaccination of melanoma patients with peptide-or tumour lysate-pulsed dendritic cells. Nature Medicine, 4, 328-332.
15. Ockert, D., Schmitz, M., Hampl, M. & Rieber, E.P. (1999) Advances in cancer immune-therapy. Immunology Today. 20, 63-65.
16. Randolph, G.J.. Beaulieu, S., Lebecque, S., Steinman, R.M. & Muller, W.A. (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science, 282, 480-483.
17. Reid, C.D.L. (1997) The dendritic cell lineage in haemopoiesis. British Journal of Haematology. 96, 217-223.
18. Rigolin, G.M., Cuneo, A., Roberti, M.G., Bardi, A., Bigoni, R., Piva. N., Minotto, C., Agostini, P., De Angeli, C., Del Senno, L., Spanedda, R. & Castoldi, G.L. (1998) Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiologic findings. British Journal of Haematology, 103, 189-197.
19. Rigolin, G.M., Cuneo, A., Roberti, M.G., Bardi, A. & Castoldi, G. (1997) Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization. Haematologica, 82, 25-30.
20. Robinson, S.P., English, N., Jaju, R., Kearney, L., Knight, S.C. & Reid, D.L. (1998) The in-vitro generation of dendritic cells from blasts cells in acute leukaemia. British Journal of Haematology, 102, 763-771.
21. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex II compartment: downregulation by cytokines and bacterial products. Journal of Experimental Medicine, 182, 389-400.
22. Sallusto, F. & Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maitained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine, 179, 1109-1118.
23. Santiago-Scwartz, S., McCarthy, M., Tucci, J. & Carson, S.E. (1998) Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hemopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway. Blood, 92, 745-755.
24. Verhoef, G.E., De Schouwer, P., Ceuppens, J.L., Van Damme, J., Goossens, W. & Boogaerts, M.A. (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia, 6, 1268-1272.